Florentina Simader

Cardiology Research Fellow | Imperial College London

[Aaysha Cader @aayshacader]

Check out @EuroInterventio Turning Point episode 2 with @rallamee
🎧 https://t.co/DCCBjYTXEr

@DFCapodanno @PCRonline
@ShrillaB @mirvatalasnag @WomenAs1 @rajkumar_chris @ProfDFrancis @MikeFoley89 @fiyyazAJ @ShaynaChotai @FloSimader @mshunshin @NievesGonzalo1 @nickaram @Hragy

[Mamas A. Mamas @mmamas1973]

Michael foley presenting orbita 2 analysis showing that ffr and ifr predict angina benefit from pci.

Absolute values matter more than dichotimous cutoff. I would personally like to see how microvascular function fits into this @rallamee @mirvatalasnag @OKhaliqueMD @Hragy @ColletCarlos @DrPeterOKane @gap0161prevent @TTelila @alaide_chief #TCT2024

[Florentina Simader @FloSimader]

🔥🔥🔥

[Shayna Chotai @ShaynaChotai]

It was such a pleasure to join @rallamee to talk all things ESC 2024
Thank you so much @TheLancet #chloewilson

https://t.co/fyKYOasxo1

[OPCI @OPCILive]

Watch This Week's Episode of OPCI Journal Club: “ORBITA-STAR Trial and the ORBITA II Symptoms Analysis” presented by @rallamee @rajkumar_chris and @FloSimader. Joined by panelists @djc795 @JWMoses @ESHLOF and Dr. Lawrence Garcia. https://t.co/UGxktZwTiL #cardiotwitter

[Florentina Simader @FloSimader]

@mshunshin @rallamee @JACCJournals Wouldn’t have been possible without you!

[Rasha Al-Lamee @rallamee]

Just in case you thought the ORBITA team had gone on summer vacation… The first ORBITA-MOON case was completed yesterday. Another n-of-1 trial that might have some interesting results. Well done @ShaynaChotai on achieving the first of many big milestones during your PhD!

[ACC Media Center @ACCmediacenter]

#cvCAD patients who have angina are more likely to achieve symptom relief from #PCI, according to an analysis of the ORBITA-2 trial in #JACC. https://t.co/9oip2X4K2J @TCTMD @TCTMD_Caitlin

[Florentina Simader @FloSimader]

Merci Paris and #euroPCR for an incredible week and experience with the best Team and colleagues✨ @rallamee @JACCJournals @PCRonline

[Caitlin E. Cox @TCTMD_Caitlin]

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response @rallamee @FloSimader

https://t.co/g4at0uY87V

[Florentina Simader @FloSimader]

So grateful and proud to have such an incredible mentor and role model @rallamee ✨

[Rasha Al-Lamee @rallamee]

As always my team make me very proud. Today we launched our newest ORBITA fellow @FloSimader who did the most fabulous job of explaining how symptoms predict outcomes from ORBITA-2 @JACCJournals @mshunshin

[JACC Journals @JACCJournals]

.@FloSimader on #ORBITA-2 at #EuroPCR:
📌Poor correlation between symptoms & disease severity
📌Symptom nature is a powerful predictor of the placebo-controlled efficacy of #PCI
📌Rose angina & typical angina are excellent predictors of the placebo-controlled efficacy of PCI
📌Other symptoms such as SOB are poor predictors of the placebo-controlled efficacy of PCI

[PCRonline 🫀 @PCRonline]

#ICYMI @aayshacader asked @rallamee & @FloSimader to summarize the symptom-stratified analysis of ORBITA-2 presented at #EuroPCR!

[Michael Foley @MikeFoley89]

The symptom stratified analysis of ORBITA2 and the ORBITA-STAR trial both presented at #EuroPCR2024 and simultaneously published in @JACCJournals by @FloSimader and @rajkumar_chris. PCI isn’t a therapy for all symptoms, it’s a therapy for angina @rallamee @mshunshin

[Antonin Trimaille @A_Trimaille]

🔥 Important new insights from ORBITA-2 study presented today at #EuroPCR

👉🏼 More angina symptoms do not necessarily reflect more extended coronary disease

👉🏼 The clinical history is a strong predictor of the efficacy of PCI

🚨Interroge your patients!

@PCRonline @rallamee

[JACC Journals @JACCJournals]

#EuroPCR #JACC LBCT SimPub: #ORBITA-2 symptom-stratified analysis - Although symptom severity & nature were poorly associated with disease severity, the nature of symptoms powerfully predicted the placebo-controlled efficacy of #PCI. https://t.co/gTBH37zmyo

@FloSimader @rallamee

[Mona Tirén @monaltiren]

…and this:

O R B I T A 2:

symptom-stratified analysis

⏰ 15/05 8:30

📍 Theatre Havane

👋 Florentina Simader
@rallamee

[Rasha Al-Lamee @rallamee]

Impact not impact factor - a new vision from @hmkyale for the new #JACC

[Christopher Rajkumar @rajkumar_chris]

Q: Does blinding matter in RCTs of surgical procedures? A: Depends on the endpoint @JAMASurgery

We compared placebo-controlled and open-label surgical trials to identify when the placebo effect is most powerful @rallamee @KatieEljadi @ImperialNHLI

https://t.co/CWdvfyQaJ0

[Arif Khokhar @DrArifK]

Delighted to bring our EAPCI Journal club to 🇬🇧

Discussing #ORBITA2 and the fantastic work by the team:

@rallamee @rajkumar_chris @MikeFoley89 @fiyyazAJ @FloSimader @ProfDFrancis